Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving cancer therapy through p53 management.

Susan Haupt1, Ygal Haupt

  • 1Department of Pharmaceutics, School of Pharmacy, Hadassah Medical School, The Hebrew University, Jerusalem, Israel.

Cell Cycle (Georgetown, Tex.)
|July 16, 2004
PubMed
Summary

Restoring the tumor suppressor p53

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editor's Note: Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53.

Cancer research·2026
Same author

Author Correction: Regulation of nucleotide metabolism by mutant p53 contributes to its gain-of-function activities.

Nature communications·2026
Same author

Establishing the Link between X-Chromosome Aberrations and <i>TP53</i> Status, with Breast Cancer Patient Outcomes.

Cells·2023
Same author

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Cell death and differentiation·2023
Same author

Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss.

Cell death & disease·2022
Same author

Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status.

Cancers·2022

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor suppressor p53 is crucial for cellular responses to stress.
  • Loss of p53 function can lead to cancer development.
  • Restoring p53 activity is a therapeutic strategy for malignancy.

Purpose of the Study:

  • To review promising p53-based cancer therapies.
  • To discuss strategies currently in clinical trials.
  • To explore innovative p53-targeting concepts.

Main Methods:

  • Review of clinical trials involving p53-based therapies.
  • Analysis of novel therapeutic concepts targeting p53.
  • Synopsis of methods to restore or mimic p53 functions.

Main Results:

  • Several p53-based strategies are under clinical investigation.
  • Innovative approaches aim to re-engage p53 in cancer cells.
  • Gene therapy and p53 reactivation show therapeutic potential.

Conclusions:

  • p53-based strategies represent a promising avenue for cancer treatment.
  • Restoring wild-type p53 function is a key therapeutic goal.
  • Ongoing research continues to develop novel p53-targeting therapies.

Related Experiment Videos